Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Plasma vitamin D levels showed a decreasing trend in the OP group and were significantly lower than those in the Con group (t = − 2.701, p = 0.008).
Source: Bone health-related indicators. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Integration of metabolomics and machine learning algorithm for discovery of early diagnostic biomarkers of osteoporosis
Study design awaiting verification · Metabolomics · 2026
Original publication title
Integration of metabolomics and machine learning algorithm for discovery of early diagnostic biomarkers of osteoporosis
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Osteoporosis (OP) is a prevalent metabolic bone disorder and a major public health concern characterized by reduced bone mass and bone microstructural deterioration. Early identification of osteoporosis and implementation of preventive interventions remain critical for reducing fracture risk and disease burden. Identifying plasma biomarkers reflecting metabolic alterations related to OP may facilitate early detection and risk assessment.
Source: BackgroundAbstract: What methods does the paper describe?
Untargeted metabolomics and lipidomics profiling based on ultra-performance liquid chromatography-mass spectrometry (UHPLC-MS) was performed in a discovery cohort comprising 75 patients with OP and 140 healthy controls. Differential features were identified using multivariate statistical analysis (PCA, OPLS-DA), and FDR-adjusted univariate analysis. Multivariable logistic regression and LASSO-regularized logistic regression was employed, with age and sex incorporated as mandatory covariates to identify independent lipid predictors. A Random Forest (RF) model was further evaluated in an independent validation cohort consisting of 20 OP patients and 42 healthy controls.
Source: MethodsAbstract: Result
Sixty-one differential metabolites were identified, primarily enriched in lipid metabolism pathways. Further targeted lipidomics identified four diagnostic lipid biomarkers, including LPA(16:0), LPI(16:0), LPI(18:0), and LPI(20:0). Following covariate adjustment for age and sex, key lipid species remained independently associated with OP. The RF-based diagnostic model maintained robust performance in the validation cohort, yielding an AUC of 0.916 (95% CI: 0.842 to 0.990), with high sensitivity and specificity.
Source: ResultAbstract: Conclusions
LPA(16:0), LPI(16:0), LPI(18:0), and LPI(20:0) in plasma were negatively correlated with the T value of bone mineral density. These associations persisted after stringent adjustment for age and sex, suggesting that lysophospholipid dysregulation is an independent metabolic hallmark of OP. The multi-metabolites model based on four biomarkers showed promising predictive performance for OP and may provide a potential tool for early risk assessment.
Source: ConclusionsAuthors’ abstract
Background
Osteoporosis (OP) is a prevalent metabolic bone disorder and a major public health concern characterized by reduced bone mass and bone microstructural deterioration. Early identification of osteoporosis and implementation of preventive interventions remain critical for reducing fracture risk and disease burden. Identifying plasma biomarkers reflecting metabolic alterations related to OP may facilitate early detection and risk assessment.
Methods
Untargeted metabolomics and lipidomics profiling based on ultra-performance liquid chromatography-mass spectrometry (UHPLC-MS) was performed in a discovery cohort comprising 75 patients with OP and 140 healthy controls. Differential features were identified using multivariate statistical analysis (PCA, OPLS-DA), and FDR-adjusted univariate analysis. Multivariable logistic regression and LASSO-regularized logistic regression was employed, with age and sex incorporated as mandatory covariates to identify independent lipid predictors. A Random Forest (RF) model was further evaluated in an independent validation cohort consisting of 20 OP patients and 42 healthy controls.
Result
Sixty-one differential metabolites were identified, primarily enriched in lipid metabolism pathways. Further targeted lipidomics identified four diagnostic lipid biomarkers, including LPA(16:0), LPI(16:0), LPI(18:0), and LPI(20:0). Following covariate adjustment for age and sex, key lipid species remained independently associated with OP. The RF-based diagnostic model maintained robust performance in the validation cohort, yielding an AUC of 0.916 (95% CI: 0.842 to 0.990), with high sensitivity and specificity.
Conclusions
LPA(16:0), LPI(16:0), LPI(18:0), and LPI(20:0) in plasma were negatively correlated with the T value of bone mineral density. These associations persisted after stringent adjustment for age and sex, suggesting that lysophospholipid dysregulation is an independent metabolic hallmark of OP. The multi-metabolites model based on four biomarkers showed promising predictive performance for OP and may provide a potential tool for early risk assessment.
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1007/s11306-026-02506-5.
Publication and source details
Original title: Integration of metabolomics and machine learning algorithm for discovery of early diagnostic biomarkers of osteoporosis
Jing Liu; Jialong Wang; Zhijun Bao; Jingkun Jia; Jinru Jia; Lifeng Han; Jinghui Du; Erwei Liu
Metabolomics · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Tianjin Municipal Education Commission Research Project2024ZD002Liu ErweiRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:07:22.467084+00:00
DOI: 10.1007/s11306-026-02506-5 · PMC13369700